John Paulson started to build up the position in GSK Plc in Q4 2016 and continued to invest until Q1 2017. Since then they sold 415 Thousand shares. The investor completely sold their stake between Q2 2017 and Q3 2017.
Avg closing price
Price range
Sold -290 Thousand shares
Q3 2017
Avg closing price
$40.59
Price range
$38.68
-
$42.77
Sold 30.3% shares (-126 Thousand shares)
Q2 2017
Avg closing price
$42.65
Price range
$40.68
-
$44.37
Increased shares by 40.2% (+119 Thousand shares)
Q1 2017